Gilead recalls Emtriva; FDA approves Ranbaxy's Tricor generic;

> Gilead Sciences ($GILD) is recalling 6,290 bottles of HIV medication Emtriva because of leaky caps. Notice

> Actavis ($ACT) is recalling nearly 47,000 cartons of vancomycin hydrochloride capsules manufactured by Patheon because they may exceed potency specifications. Notice

> Invetech has a new deal with Argos Therapeutics ($ARGS) to supply manufacturing systems which it can use with its platform to make its immunotherapy cancer drugs. Release

> The FDA has approved Ranbaxy Laboratories' fenofibrate capsules, a generic of Abbott Laboratories' ($ABT) high blood pressure med Tricor, which Ranbaxy is manufacturing at its Ohm Laboratories plant in New Jersey. Release

> An audit found that the number of pharma facilities passing inspections by regulator TGA improved in the last year, with 93% of foreign firms being rated satisfactory, while 89% of domestic firms made that grade. Story (sub. req.)

> A 68-year-old Pheonix, AZ man has been sentenced to two years of supervised probation for selling counterfeit Viagra online. Story